Although the FA-induced activation of NOD-like receptor (NLR) NLRP3 inflammasome, which promotes IL-1β production, has been implicated in the progression of NAFLD to NASH (265–267), the potential role of estrogens in directly modulating NLRP3 inflammasome in the progression of NAFLD to NASH has been very poorly investigated (268) and remains unclear. This evidence concerns the gene IL1B and metabolic dysfunction-associated steatotic liver disease.